Celestica, Inc. $CLS Shares Acquired by Fulcrum Asset Management LLP

Fulcrum Asset Management LLP boosted its position in Celestica, Inc. (NYSE:CLS – Free Report) (TSE:CLS) by 255.5% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 12,222 shares of the technology company’s stock after acquiring an additional 8,784 shares during the period. Fulcrum Asset Management LLP’s holdings in Celestica were worth $4,476,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CLS. Allspring Global Investments Holdings LLC increased its stake in shares of Celestica by 1,035.1% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 36,982 shares of the technology company’s stock valued at $13,797,000 after acquiring an additional 33,724 shares during the last quarter. Elite Wealth Management Inc. boosted its position in shares of Celestica by 19.6% in the third quarter. Elite Wealth Management Inc. now owns 19,913 shares of the technology company’s stock worth $7,197,000 after acquiring an additional 3,265 shares during the last quarter. M Holdings Securities Inc. acquired a new stake in shares of Celestica in the third quarter worth approximately $708,000. Ethic Inc. boosted its position in shares of Celestica by 24.6% in the third quarter. Ethic Inc. now owns 4,217 shares of the technology company’s stock worth $1,524,000 after acquiring an additional 833 shares during the last quarter. Finally, Pictet Asset Management Holding SA grew its holdings in Celestica by 94.4% in the third quarter. Pictet Asset Management Holding SA now owns 1,068,473 shares of the technology company’s stock valued at $386,578,000 after purchasing an additional 518,798 shares during the period. 67.38% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Celestica news, President Todd Cooper sold 20,118 shares of the company’s stock in a transaction on Wednesday, September 23rd. The stock was sold at an average price of $360.00, for a total value of $7,242,480.00. Following the transaction, the president owned 73,252 shares of the company’s stock, valued at approximately $26,370,720. This represents a 21.55% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Robert Mionis sold 23,396 shares of Celestica stock in a transaction that occurred on Wednesday, September 23rd. The stock was sold at an average price of $364.22, for a total transaction of $8,521,291.12. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 67,010 shares of company stock worth $24,278,487 over the last quarter. Insiders own 1.10% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. RBC Dominion Securities set a $450.00 price objective on Celestica and gave the stock an “outperform” rating in a report on Friday, October 23rd. Wolfe Research lifted their target price on Celestica from $425.00 to $475.00 and gave the company an “outperform” rating in a report on Wednesday, July 29th. Wall Street Zen upgraded Celestica from a “hold” rating to a “buy” rating in a report on Saturday. Canadian Imperial Bank of Commerce boosted their price target on Celestica from $480.00 to $500.00 and gave the company an “outperform” rating in a research report on Wednesday, July 29th. Finally, BMO Capital Markets restated an “outperform” rating and set a $400.00 price target on shares of Celestica in a research note on Friday, October 23rd. Two analysts have rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of $445.14.

View Our Latest Report on Celestica

Celestica Price Performance

CLS opened at $223.62 on Tuesday. The firm has a market cap of $28.20 billion, a price-to-earnings ratio of 25.37, a price-to-earnings-growth ratio of 0.63 and a beta of 2.10. Celestica, Inc. has a fifty-two week low of $197.50 and a fifty-two week high of $474.02. The company has a quick ratio of 1.03, a current ratio of 1.61 and a debt-to-equity ratio of 0.13. The company’s 50-day moving average price is $315.80 and its 200 day moving average price is $328.76.

Celestica (NYSE:CLS – Get Free Report) (TSE:CLS) last posted its earnings results on Monday, October 26th. The technology company reported $3.30 EPS for the quarter, topping the consensus estimate of $3.02 by $0.28. Celestica had a net margin of 6.83% and a return on equity of 33.80%. The firm had revenue of $5.74 billion during the quarter, compared to analysts’ expectations of $5.39 billion. As a group, sell-side analysts expect that Celestica, Inc. will post 10.97 earnings per share for the current year.

Celestica Company Profile

(Free Report)

Celestica Inc is a global provider of design, manufacturing, and supply chain services for companies across technology and industrial markets. Its work spans product development, engineering, manufacturing, testing, and ongoing product support.

The company’s offerings include hardware and infrastructure used in cloud computing and data centers, communications networks, aerospace and defense, industrial equipment, and health technology. It also provides supply chain management and other services to support products throughout their lifecycle.

Celestica traces its roots to IBM’s manufacturing operations and became an independent company in 1996.

Featured Articles

Want to see what other hedge funds are holding CLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Celestica, Inc. (NYSE:CLS – Free Report) (TSE:CLS).

Institutional Ownership by Quarter for Celestica (NYSE:CLS)

Receive News & Ratings for Celestica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celestica and related companies with MarketBeat.com's FREE daily email newsletter.